PIEZO1 gain-of-function mutations delay reticulocyte maturation in hereditary xerocytosis. - Abstract - Europe PMC
Haematologica, Volume 107, Issue 11 by Haematologica - Issuu
Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency | Haematologica
Impaired bone marrow microenvironment and stem cells in transfusion-dependent beta-thalassemia - ScienceDirect
PDF) Italian Society of Hematology Practice Guidelines for the management of iron overload in thalassemia major and related disorders
Validation of Several Formulas to Differentiate Thalassemia from Iron Deficiency Anemia and Proposal of a Thalassemia–Iron Deficiency Discrimination (TID) Predictive Score | Siriraj Medical Journal
Anemie
PDF) Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: Indications and management recommendations from an international expert panel
PDF) Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia | Hani Tamim - Academia.edu
PDF) Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders | M. Marchetti - Academia.edu
Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin | Haematologica
Vol. 104 No. 3 (2019): March, 2019 | Haematologica
Evaluation of the diagnostic reliability of Mentzer index for Beta thalassemia trait followed by HPLC
Haematologica, Volume 105, Issue 11 by Haematologica - Issuu
Diagnostics | Free Full-Text | The TVGH-NYCU Thal-Classifier: Development of a Machine-Learning Classifier for Differentiating Thalassemia and Non-Thalassemia Patients
Sotatercept, a novel transforming growth factor ß ligand trap, improves anemia in ß-thalassemia: a phase II, open-label, dose-
PDF) Resveratrol accelerates erythroid maturation by activation of FOXO3 and ameliorates anemia in beta-thalassemic mice
Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-
Ferrata Storti Foundation
s3 - Supplements - Haematologica
PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
Ferrata Storti Foundation
